EUVIMEDEUVIMED entdecken
VergleichsstudieMultizentrische StudieOpen Access · CC BY 4.0

Comparing moderate–severe and severe mitral regurgitation in transcatheter aortic valve replacement on 1-year survival: insights from a Japanese Nationwide Registry

Kaoru Matsuura, Hiraku Kumamaru, Shun Kohsaka, Tomoyoshi Kanda, Hideki Kitahara, Kazuo Shimamura, Yoshio Kobayashi, Goro Matsumiya

Heart and Vessels · 2025-06 · 40 (6) · 523-530

DOI: 10.1007/s00380-024-02491-6 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Heart and Vessels, online erschienen am 19.12.2024. Verfasst von Kaoru Matsuura und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Chiba University Graduate School of Medicine, Chiba University Hospital, 1-8-1 Inohana, Chuo Ward, Chiba, Chiba…. Hauptthemen laut MEDLINE: Mitral Valve Insufficiency, Transcatheter Aortic Valve Replacement, Registries, Aortic Valve Stenosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aims to compare 1-year outcomes after transcatheter aortic valve replacement (TAVR) between patients with moderate–severe MR and severe MR preoperatively using the Japan Transcatheter Valve Therapy (J-TVT) registry. Patients undergoing TAVR for aortic stenosis between August 2013 and December 2019 with preoperative mitral regurgitation of moderate–severe (group MR3) or severe (group MR4) were included. Patients with a history of valve surgery and dialysis patients were excluded. A total of 2017 patients were included, and 1-year follow-up data were obtained from the registry (follow-up rate 98.5%). Propensity-score matching between MR3 and MR4 groups was performed. All-cause mortality and the composite outcome of death and/or heart failure events were compared. Crude data showed that 1-year survival was significantly higher in the MR 3 (89.8%) than MR 4 (84.7%) groups, and freedom from 1-year mortality and heart failure events was also higher in the MR 3 (87.1%) than MR 4 (80.5%) groups ( p = 0.0001). After propensity-score matching, 452 cases (226 cases each in MR 3 group and MR 4 group) were extracted. Cox regression model showed no statistical difference in the 1-year survival rate between MR 3 group (84.5%) and MR 4 group (85.5%) ( p = 0.84), nor in freedom from 1-year death and/or heart failure events between MR 3 group (80.2%) and MR 4 group (81.6%) ( p = 0.72). The 1-year survival rate and freedom from death and/or heart failure events were found to be similar between patients undergoing TAVR with MR grade 3 and MR grade 4.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mitral Valve InsufficiencyTranscatheter Aortic Valve ReplacementRegistriesAortic Valve StenosisAortic ValveMitral ValveHumansMaleJapanFemaleAged, 80 and overSeverity of Illness IndexTime FactorsSurvival RateTreatment OutcomeRetrospective StudiesAgedFollow-Up StudiesPropensity ScoreRisk FactorsEast Asian People

Stichwörter der Autor:innen

Aortic valve replacement/implantationOutcomesPrognosisTranscatheter

Autor:innen und Institutionen

  • Department of Cardiovascular Surgery, Chiba University Graduate School of Medicine, Chiba University Hospital, 1-8-1 Inohana, Chuo Ward, Chiba, Chiba, 260-0856, Japan. km4717jp@yahoo.co.jp.
  • Department of Healthcare Quality Assessment, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.
  • Department of Cardiovascular Surgery, Chiba University Graduate School of Medicine, Chiba University Hospital, 1-8-1 Inohana, Chuo Ward, Chiba, Chiba, 260-0856, Japan.
  • Department of Cardiology, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Suita, Japan.

Zitieren

APA

Matsuura, K., Kumamaru, H., Kohsaka, S., Kanda, T., Kitahara, H., Shimamura, K., Kobayashi, Y., & Matsumiya, G. (2025). Comparing moderate–severe and severe mitral regurgitation in transcatheter aortic valve replacement on 1-year survival: insights from a Japanese Nationwide Registry. Heart and Vessels, 40(6), 523-530. https://doi.org/10.1007/s00380-024-02491-6

Vancouver

Matsuura K, Kumamaru H, Kohsaka S, Kanda T, Kitahara H, Shimamura K, et al. Comparing moderate–severe and severe mitral regurgitation in transcatheter aortic valve replacement on 1-year survival: insights from a Japanese Nationwide Registry. Heart and Vessels. 2025;40(6):523-530. doi:10.1007/s00380-024-02491-6

BibTeX
@article{Matsuura2025,
  author = {Matsuura, Kaoru and Kumamaru, Hiraku and Kohsaka, Shun and Kanda, Tomoyoshi and Kitahara, Hideki and Shimamura, Kazuo and Kobayashi, Yoshio and Matsumiya, Goro},
  title = {Comparing moderate–severe and severe mitral regurgitation in transcatheter aortic valve replacement on 1-year survival: insights from a Japanese Nationwide Registry},
  journal = {Heart and Vessels},
  year = {2025},
  volume = {40},
  number = {6},
  pages = {523--530},
  doi = {10.1007/s00380-024-02491-6}
}
Kostenlos starten →